ArticleClinical journal of oncology nursing2022

Tepotinib: Management of Adverse Events in Patients With MET Exon 14 Skipping Non-Small Cell Lung Cancer.

Linda Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.